Beyond TNF: TNF superfamily cytokines as targets for the treatment of rheumatic diseases
Crossref DOI link: https://doi.org/10.1038/nrrheum.2017.22
Published Online: 2017-03-09
Published Print: 2017-04
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Croft, Michael
Siegel, Richard M.
Text and Data Mining valid from 2017-03-09
Version of Record valid from 2017-03-09
Article History
First Online: 9 March 2017
Competing interests
: M.C. has licensed patents on several TNF superfamily molecules. R.S. has issued patents on antibodies against the TNF superfamily molecule TL1A.